Investments
37Portfolio Exits
6Funds
1About Seroba Life Sciences
Seroba Life Sciences, fka Seroba Kernel Life Sciences, is a European venture capital firm that invests across the spectrum of the life science industry including medical devices, biotechnology, specialty pharmaceuticals, therapeutic drugs, medical technology, diagnostics, instrumentation, and other selected opportunities. Seroba funds new healthcare opportunities through key value-adding stages, from inception through development and clinical evaluation, the generation of intellectual property, regulatory approvals and market launch, and partnering pharmaceutical or medtech companies.
Seroba Life Sciences Headquarter Location
6 Northbrook Road Ranelagh
Dublin, D06 PH32,
Ireland
+353 (0)1 633 4028
Expert Collections containing Seroba Life Sciences
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Seroba Life Sciences in 1 Expert Collection, including Pharma Startups.
Pharma Startups
5,090 items
Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.
Latest Seroba Life Sciences News
Aug 2, 2021
Bird & Bird advised Coave Therapeutics (Horama SAS) with a team including Emmanuelle Porte (Picture – Corporate M&A). McDermott Will & Emery advised Fund+, Go Capital, Idinvest Partners, Kurma Partners, Omnes Capital, Seroba Life Sciences, Sham Innovation Santé, V-Bio Ventures with a team including Anthony Paronneau (Corporate M&A). Weil, Gotshal & Manges advised Théa Open Innovation with a team including Fr?
Seroba Life Sciences Investments
37 Investments
Seroba Life Sciences has made 37 investments. Their latest investment was in Coave Therapeutics as part of their Series B - III on July 7, 2021.
Seroba Life Sciences Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
7/21/2021 | Series B - III | Coave Therapeutics | $25.1M | Yes | 3 | |
6/28/2021 | Series A | Palliare | $8M | Yes | SCM AD Ventures, Undisclosed Angel Investors, and Western Development Commission | 3 |
6/23/2021 | Series D | Quanta Dialysis Technology | $245M | No | Ancora Investment Holdings, BlackRock, btov Partners, Eldridge, Glenview Capital Management, Grand Ventures, Millennium Management, Monashee Investment Management, Novo Holdings, Orlando Health Strategic Innovations, Puhua Capital, Sands Capital, Segulah Medical Acceleration, and Wellington Partners | 6 |
6/3/2020 | Series A | |||||
10/1/2019 | Series D - II |
Date | 7/21/2021 | 6/28/2021 | 6/23/2021 | 6/3/2020 | 10/1/2019 |
|---|---|---|---|---|---|
Round | Series B - III | Series A | Series D | Series A | Series D - II |
Company | Coave Therapeutics | Palliare | Quanta Dialysis Technology | ||
Amount | $25.1M | $8M | $245M | ||
New? | Yes | Yes | No | ||
Co-Investors | SCM AD Ventures, Undisclosed Angel Investors, and Western Development Commission | Ancora Investment Holdings, BlackRock, btov Partners, Eldridge, Glenview Capital Management, Grand Ventures, Millennium Management, Monashee Investment Management, Novo Holdings, Orlando Health Strategic Innovations, Puhua Capital, Sands Capital, Segulah Medical Acceleration, and Wellington Partners | |||
Sources | 3 | 3 | 6 |
Seroba Life Sciences Portfolio Exits
6 Portfolio Exits
Seroba Life Sciences has 6 portfolio exits. Their latest portfolio exit was PQ Bypass on April 13, 2021.
Seroba Life Sciences Fund History
1 Fund History
Seroba Life Sciences has 1 fund, including Seroba Life Sciences Fund III.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
2/2/2017 | Seroba Life Sciences Fund III | $108.08M | 3 |
Closing Date | 2/2/2017 |
|---|---|
Fund | Seroba Life Sciences Fund III |
Fund Type | |
Status | |
Amount | $108.08M |
Sources | 3 |